Advanced Computational Solid – State Services

In collaboration with XtalPi, Inc., Solitek is proud to offer an advanced suite of computational solid-state services, enhancing solid-form research through artificial intelligence and quantum physics-based technologies. Our partnership with XtalPi allows us to provide faster, more accurate insights into crystal structure prediction and evaluation, counterion/coformer selection for salt/cocrystals, and micro electron diffraction analysis, significantly reducing the experimental burden on our clients while accelerating drug development timelines.

Advanced Computational Solid – State Services

Key concepts

XtalPi has created an innovative solid-state R&D platform that seamlessly integrates computational chemistry with advanced artificial intelligence technology. This platform delivers rapid, accurate, and reliable results, even when dealing with complex molecular systems. Supported by an abundance of unlimited computation resources and excellent computational experts, XtalPi’s AI-powered solid-state R&D platform has been validated and is trusted by leading industry experts to empower the pharmaceutical solid-state R&D process beyond industry standards.

  • Crystal Structure Prediction (CSP): XtalPi’s proprietary Crystal Structure Prediction (CSP) performs the global search of crystal structures of the target molecule and the other optional components in the corresponding searching space, identifying the most thermodynamically stable crystalline form at room temperature and the relative stability between stable forms, covering a wide variety of systems including polymorphs, salts, cocrystals, hydrates/solvates, etc.
  • Counterion/Coformer Selection for Salt/Cocrystal Studies: Through XtalPi’s AI-powered solid-state virtual screening platform, we offer a revolutionary approach to counterion/coformer/solvent By computing the interaction between the target API and selected solvents, coformers, counter-ions and carriers, the platform solves problems such as the difficulty of selecting the optimal counterion/coformer/solvent conditions among numerous options and the long experimental verification cycle for the physical stability of solid dispersion, thereby improving the efficiency and success rate of experimental screening.
  • Morphology Prediction: XtalPi has developed models to predict the crystal morphology of given polymorphs under different crystallization conditions, exploring the variability and controllability of morphology under factors such as solvent type, supersaturation, and temperature. By adjusting the crystallization conditions, the original morphology of the target polymorph can be changed more purposefully to accelerate the development of crystallization processes.
  • Micro Electron Diffraction (MicroED): XtalPi has developed a highly automated MicroED crystal structure analysis platform, which can achieve high-precision crystal structure determination in as little as one day. This innovative platform eliminates the need for single crystal cultivation and only requires a milligram level crystalline powder sample. To date, they have accurately determined the crystal structure of over 300 small-molecule drugs with more than 90% success rate.

It is equipped with cutting-edge instrumentation such as a ThermoFisher Scientific Glacios 200 kV Cryo-Transmission Electron Microscope, a Ceta-D camera, a Falcon 4 Direct Detection Camera, and a Vitrobot Mark IV System for specimen preparation.

  • Tailored Computational Solutions: We customize our computational workflows based on each API’s unique properties, ensuring accurate and efficient predictions.
  • Comprehensive Support: Our team works closely with clients to integrate computational findings with experimental work, providing seamless project management from prediction to validation.

This collaboration harnesses Solitek’s expertise in solid-state chemistry and XtalPi’s cutting-edge AI and quantum physics platforms, providing clients with unparalleled computational tools that are accurate, reliable, and fast. Our comprehensive services help accelerate drug development, de-risk solid form research, and optimize outcomes for pharmaceutical innovations.

At Solitek, quality and innovation are at the forefront of our services. We continuously invest in the latest technologies and methodologies to maintain our position as leaders in solid form screening and selection. Our rigorous quality control processes ensure reliable and reproducible results, providing our clients with confidence in their data and decisions. We are dedicated to staying ahead of industry trends and incorporating cutting-edge technologies into our workflows to deliver superior results.

Computational Chemist

Case Studies and Success Stories

Our collaborations with various pharmaceutical companies have led to overcoming significant challenges related to solid form screening and selection. Through tailored solutions and expert insights, we have helped accelerate drug development timelines and improve product performance. For instance, we have conducted cocrystal selection studies applying a preliminary coformer ranking exercise, using XtalPi’s virtual screening platform, and we have doubled the success rate from 10-15% to over 30% compared to previous methods, meaning that by integrating state-of-the-art computational methods, we have a much higher chance of finding a novel cocrystal with the right physical properties while reducing experimental efforts and time.

Conclusion

Understanding solid form and being able to predict and modulate the physical properties of our drug candidates is fundamental in pharmaceutical development, influencing drug quality, efficacy, and manufacturability. Solitek not only offers comprehensive, customized, and high-quality screening and selection services, but we also engage with technology experts beyond the confines of Solitek to bring you the most advanced solutions. Choosing Solitek ensures that your drug development program benefits from the best in solid form science, leading to successful outcomes and innovative therapies for patients.